WEDNESDAY, Feb. 5, 2025 (HealthDay News) — Hopes that GLP-1 drugs such as Ozempic and Wegovy could help slow Parkinson’s disease have taken an hit. A new study found that a drug in the same class called exenatide, marketed as Byetta, had no effect on slowing the disease or easingContinue Reading
TUESDAY, Feb. 4, 2025 (HealthDay News) — Many Americans don’t see anything wrong with taking daily low-dose aspirin, even though experts have concluded its risks outweigh its benefits, a new survey has found. Nearly half (48%) of people incorrectly think that the benefits of taking low-dose aspirin daily to reduceContinue Reading
TUESDAY, Feb. 4, 2025 (HealthDay News) — Drugs like blood thinners, cholesterol-lowering statins and blood pressure meds can protect the health and extend the lives of people with heart disease. But only if patients take the drugs — and many around the world aren’t, a new study says. Overall, fewerContinue Reading
FRIDAY, Jan. 31, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin. The new pill, developed by Vertex Pharmaceuticals, is intended for short-term pain relief following surgeryContinue Reading
WEDNESDAY, Jan. 29, 2025 (HealthDay News) — Daily low-dose aspirin can help prevent cancers from returning in about a third of colon cancer patients, a new study says. Taking 160 milligrams of aspirin a day cuts the risk of cancer recurrence in half among colon cancer patients with a mutationContinue Reading
WEDNESDAY, Jan. 29, 2025 (HealthDay News) — COVID-19 continues to be a threat to America’s health, causing more illness and death than either influenza or respiratory syncytial virus (RSV), a new study suggests. COVID accounted for 3 of 5 (60%) respiratory illnesses among military veterans treated by the U.S. VeteransContinue Reading
FRIDAY, Jan. 24, 2025 (HealthDay News) — Hesitancy over the COVID-19 vaccine is leading some parents to skip important vaccinations for their children. Young children of parents who declined the COVID vaccine are about 25% less likely to get the standard measles/mumps/rubella (MMR) vaccine, researchers reported in a new studyContinue Reading
FRIDAY, Jan. 24, 2025 (HealthDay News) — People using weed for medical purposes are as likely – or more – to become addicted to cannabis as recreational tokers, a new study says. Folks using medical marijuana were more likely to have cannabis use disorder than those who get high recreationally,Continue Reading
Agency cites contamination at Massachusetts plant where company makes ingredients used to produce various medicinesContinue Reading
-690x550.jpg)
THURSDAY, Jan. 23, 2025 (HealthDay News) — Preventing or treating infections could be a key means of warding off dementia, a new evidence review says. Vaccines, antibiotics, antiviral medications and anti-inflammatory drugs are all associated with a reduced risk of dementia, researchers reported in a study published Jan. 21 inContinue Reading
Drug is the first and only approved monotherapy for refractory major depressive disorderContinue Reading
WEDNESDAY, Jan. 22, 2025 (HealthDay News) — With a sweep of the pen, President Donald Trump has ended a Biden administration effort to lower the cost of prescription drugs for people on Medicare and Medicaid. Trump’s order, signed shortly after his inauguration on Monday, targets policies his administrations calls “deeplyContinue Reading
TUESDAY, Jan. 21, 2025 (HealthDay News) — The U.S. Department of Health and Human Services (HHS) is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu. This funding, announced Friday by Moderna, builds on the $176 million it received from HHS lastContinue Reading
TUESDAY, Jan. 21, 2025 (HealthDay News) — Popular GLP-1 medications for weight loss and diabetes may have unexpected benefits for reducing risks for conditions such as substance abuse, psychosis, infections and even dementia. But these drugs also come with risks that shouldn’t be overlooked, researchers warn in a study publishedContinue Reading